| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.766 | 1.734 | 722 | 607 | 44.170 | 61.211 | 75.266 | 80.430 | 86.827 |
| Total Income - EUR | - | 2.766 | 1.734 | 722 | 611 | 44.171 | 61.213 | 75.267 | 80.445 | 86.849 |
| Total Expenses - EUR | - | 770 | 943 | 3.579 | 5.166 | 26.565 | 32.623 | 44.659 | 46.386 | 52.382 |
| Gross Profit/Loss - EUR | - | 1.995 | 790 | -2.857 | -4.555 | 17.606 | 28.590 | 30.608 | 34.059 | 34.467 |
| Net Profit/Loss - EUR | - | 1.912 | 738 | -2.878 | -4.568 | 17.164 | 27.978 | 29.856 | 33.255 | 31.862 |
| Employees | - | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Chirtesmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 11.478 | 8.975 | 6.554 | 5.074 | 4.055 | 33.227 | 26.060 | 15.776 |
| Current Assets | - | 2.040 | 1.162 | 1.386 | 1.019 | 22.972 | 42.328 | 84.390 | 54.011 | 65.203 |
| Inventories | - | 0 | 0 | 0 | 305 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 123 | 0 | 515 | 253 | 253 | 22.963 | 4.266 | 270 |
| Cash | - | 2.040 | 1.040 | 1.386 | 199 | 22.719 | 42.075 | 61.427 | 49.745 | 64.933 |
| Shareholders Funds | - | 1.957 | 2.662 | -265 | -4.828 | 12.428 | 40.130 | 29.904 | 40.734 | 72.368 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 83 | 9.978 | 10.627 | 12.401 | 15.636 | 6.252 | 87.713 | 39.337 | 8.612 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Chirtesmed Srl